NCT04104893 2026-02-27
CHOMP
VA Office of Research and Development
Phase 2 Active not recruiting
Clinical Trials
18 trialsNCT05796375 2026-01-30
ReplaceCysto
White River Junction Veterans Affairs Medical Center
Phase 2 Recruiting
NCT06084338 2025-12-31
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
VA Office of Research and Development
Phase 2 Recruiting
NCT03298087 2025-08-01
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
VA Office of Research and Development
Phase 2 Completed
NCT06610825 2025-07-28
CaRPET
Washington D.C. Veterans Affairs Medical Center
Phase 2 Recruiting
NCT05011383 2025-07-09
VA-BAT
VA Office of Research and Development
Phase 2 Recruiting
NCT04390880 2025-05-16
PROSPYL
VA Greater Los Angeles Healthcare System
Phase 2 Completed
NCT05593497 2025-04-16
SNARE
VA Office of Research and Development
Phase 2 Recruiting
NCT01759771 2024-03-18
VD3PCa
VA Office of Research and Development
Phase 2 Completed
NCT05820724 2023-04-24
PSMA PET Scan and mpMRI for Prostate Cancer Detection
VA Greater Los Angeles Healthcare System
Phase 2 Not yet recruiting
NCT04116775 2022-06-23
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
Portland VA Medical Center
Phase 2 Unknown
NCT05422911 2022-06-21
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
James J. Peters Veterans Affairs Medical Center
Phase 2 Not yet recruiting
NCT03753243 2022-04-20
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Portland VA Medical Center
Phase 2 Recruiting
NCT04489745 2020-07-28
Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
VA Greater Los Angeles Healthcare System
Phase 2 Unknown
NCT00018538 2009-01-21
Calcifidol Therapy in Men With Cancer
VA Office of Research and Development
Phase 2 Completed
NCT00108290 2008-04-04
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
VA Office of Research and Development
Phase 2 Completed
NCT00215345 2005-09-22
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
Department of Veterans Affairs, New Jersey
Phase 2 Unknown
NCT00218205 2005-09-22
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Department of Veterans Affairs, New Jersey
Phase 2 Unknown